The efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials

The efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials

Jiaxing Huang,1,2,* Yaxiong Zhang,1,2,* Jin Sheng,1,2,* Hongyu Zhang,3 Wenfeng Fang,1,2 Jianhua Zhan,1,2 Ting Zhou,1,2 Ying Chen,1,2 Lin Liu,1,2 Li Zhang1,2 1Department of Medical Oncology, Sun Yat-Sen University Cancer Center, 2State Key Laboratory of Oncology in South China, 3Department of Medica...

Full description

Bibliographic Details
Main Authors: Huang J, Zhang Y, Sheng J, Zhang H, Fang W, Zhan J, Zhou T, Chen Y, Liu L, Zhang L
Format: Article
Language:English
Published: Dove Medical Press 2016-09-01
Series:OncoTargets and Therapy
Subjects:
nivolumab
PD-1
non-small cell lung cancer (NSCLC)
meta-analysis
Online Access:https://www.dovepress.com/the-efficacy-and-safety-of-nivolumab-in-previously-treated-advanced-no-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/the-efficacy-and-safety-of-nivolumab-in-previously-treated-advanced-no-peer-reviewed-article-OTT

Similar Items